SANOFI CONS HEALTHC IND L Total Assets
SANOFI CONS HEALTHC IND L total assets. Based on the latest financial reports, SANOFI CONS HEALTHC IND L (SANOFICONR) holds total assets worth Rs5.47 Billion INR (≈ $59.16 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see SANOFI CONS HEALTHC IND L stock valuation for the company's overall valuation and market capitalisation.
Total Assets of SANOFI CONS HEALTHC IND L (2023–2025)
Total assets of SANOFI CONS HEALTHC IND L from 2023 to 2025. This chart illustrates how SANOFI CONS HEALTHC IND L's total assets have evolved over time, based on quarterly financial data. See SANOFI CONS HEALTHC IND L stock price for real-time trading data and today's change.
SANOFI CONS HEALTHC IND L - Asset Composition Analysis
SANOFI CONS HEALTHC IND L Total Assets Breakdown (December 2025)
SANOFI CONS HEALTHC IND L total assets breakdown as of December 2025. SANOFI CONS HEALTHC IND L's total assets of Rs5.47 Billion consist of 90.4% current assets and 9.6% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 68.6% |
| Accounts Receivable | Rs297.00 Million | 5.4% |
| Inventory | Rs619.00 Million | 11.3% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs0.00 | 0.0% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2023–2025)
This chart illustrates how SANOFI CONS HEALTHC IND L's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of SANOFI CONS HEALTHC IND L to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SANOFI CONS HEALTHC IND L's current assets represent 90.4% of total assets in 2025, a decrease from 97.1% in 2023.
- Cash Position: Cash and equivalents constituted 68.6% of total assets in 2025, up from 0.5% in 2023.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2023.
- Asset Diversification: The largest asset category is inventory at 11.3% of total assets.
SANOFI CONS HEALTHC IND L Competitors by Total Assets
Key competitors of SANOFI CONS HEALTHC IND L based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Novartis AG
SW:NOVN
|
Switzerland | CHF118.89 Billion |
|
AstraZeneca PLC
NASDAQ:AZN
|
USA | $114.02 Billion |
|
Pfizer Inc
SA:PFIZ34
|
Brazil | R$201.13 Billion |
|
Novartis AG
MX:NVSN
|
Mexico | MX$118.53 Billion |
|
Biogen Inc
NASDAQ:BIIB
|
USA | $32.09 Billion |
|
Organon & Co
NYSE:OGN
|
USA | $13.18 Billion |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019
|
China | CN¥12.85 Billion |
|
GuangYuYuan Chinese Herbal Medicine Co Ltd
SHG:600771
|
China | CN¥2.55 Billion |
SANOFI CONS HEALTHC IND L - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.85 | 3.00 | 2.58 |
| Quick Ratio | 3.37 | 2.69 | 1.84 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs3.66 Billion | Rs2.61 Billion | Rs2.05 Billion |
SANOFI CONS HEALTHC IND L - Advanced Valuation Insights
This section examines the relationship between SANOFI CONS HEALTHC IND L's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 28.59 |
| Latest Market Cap to Assets Ratio | 0.16 |
| Asset Growth Rate (YoY) | 26.8% |
| Total Assets | Rs5.47 Billion |
| Market Capitalization | $851.86 Million USD |
Valuation Analysis
Below Book Valuation: The market values SANOFI CONS HEALTHC IND L's assets below their book value (0.16x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: SANOFI CONS HEALTHC IND L's assets grew by 26.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for SANOFI CONS HEALTHC IND L (2023–2025)
The table below shows the annual total assets of SANOFI CONS HEALTHC IND L from 2023 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Rs5.47 Billion ≈ $59.16 Million |
+26.83% |
| 2024-12-31 | Rs4.31 Billion ≈ $46.64 Million |
+24.87% |
| 2023-12-31 | Rs3.45 Billion ≈ $37.35 Million |
-- |
About SANOFI CONS HEALTHC IND L
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was in… Read more